Ledger.Open graph →
SEC Form D · filed December 22, 2022

Aethon Therapeutics, Inc

Offering
$30.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

William Engels · New York, NYExecSeth Harrison · Cambridge, MADirectorPaul Da Silva Jardine · New York, NYExec · DirectorRajesh Chopra · Cambridge, MAExec · DirectorWilliam Engels · New York, NYExecSeth Harrison · New York, NYDirectorPaul Da Silva Jardine · New York, NYExec · DirectorRajesh Chopra · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗